January 30, 2019
A Study to Describe the Immunogenicity, Safety, and Tolerability of Neisseria Meningitidis Serogroup B Bivalent Recombinant Lipoprotein 2086 Vaccine (Bivalent rLP2086) in Healthy Subjects Aged ≥24 Months to
Read More
January 30, 2019
Immunogenicity and Safety Study of GSK Biologicals’ GSK2202083A Vaccine in Healthy Infants at 2, 3 and 4 Months of Age
Read More
January 30, 2019
Immunogenicity and Safety Study of GSK Biologicals’ GSK2202083A Vaccine in Healthy Infants at 2, 3 and 4 Months of Age
Read More
January 30, 2019
Immunogenicity and Safety Study of GlaxoSmithKline Biologicals’ GSK2202083A Vaccine Administered as a Booster Dose
Read More
January 30, 2019
Immunogenicity and Safety Study of GlaxoSmithKline Biologicals’ GSK2202083A Vaccine Administered as a Booster Dose
Read More
January 30, 2019
Pneumococcal Vaccine Booster Study in Healthy Children 11-18 Months Old Previously Primed With the Same Vaccines
Read More
January 30, 2019
Pneumococcal Vaccine Booster Study in Healthy Children 11-18 Months Old Previously Primed With the Same Vaccines
Read More
January 30, 2019
An Observational Study of Pegasys (Peginterferon Alfa-2a) and Copegus (Ribavirin) on Predictive Values of RVR on Sustained Virological Response in Different Stages of Liver Fibrosis in Treatment-Naïve Patients With Chronic Hepatitis C Genotype 1
Read More
January 30, 2019
An Observational Study of Pegasys (Peginterferon Alfa-2a) in Patients With Chronic Hepatitis B Who Have Failed Antiviral Treatment With Nucleoside (Nucleotide) Analogues
Read More
December 10, 2018
A Study to Describe the Immunogenicity, Safety, and Tolerability of Neisseria Meningitidis Serogroup B Bivalent Recombinant Lipoprotein 2086 Vaccine (Bivalent rLP2086) in Healthy Subjects Aged ≥24 Months to
Read More
December 10, 2018
A Study to Investigate the Safety and Efficacy of Fidaxomicin (Oral Suspension or Tablets) and Vancomycin (Oral Liquid or Capsules) in Pediatric Subjects With Clostridium Difficile-associated Diarrhea (CDAD)
Read More
X